Tamoxifen therapy of metastatic breast cancer

Keyphrases

• Tamoxifen Therapy 100%
• Hormone-responsive 100%
• Endocrine Therapy 100%
• Metastatic Breast Cancer 100%
• Chemotherapy 66%
• Antiestrogen 33%
• Androgens 33%
• Castration 33%
• Breast Cancer 33%
• Treatment Choice 33%
• Progestin 33%
• Randomized Clinical Trial 33%
• Ovariectomy 33%
• Tissue Level 33%
• Menses 33%
• Endocrine Treatment 33%
• Estrogen Therapy 33%
• Aromatase Inhibitors 33%
• Postmenopausal Patients 33%
• Aminoglutethimide 33%
• Premenopausal Patients 33%
• Postmenopausal Breast Cancer 33%
• Estrogen Action 33%
• Maximum Benefit 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Tamoxifen 100%
• Metastatic Breast Cancer 100%
• Endocrine Therapy 50%
• Antiestrogen 33%
• Breast Cancer 33%
• Chemotherapy 33%
• Aromatase Inhibitor 16%
• Androgen 16%
• Randomized Clinical Trial 16%
• Progestin 16%
• Aminoglutethimide 16%